Silvant Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-5,576
| Closed | -$195K | – | 342 |
|
|
2019
Q1 | $195K | Hold |
5,576
| – | – | 0.04% | 190 |
|
|
2018
Q4 | $185K | Sell |
5,576
-2,695
| -33% | -$89.4K | 0.04% | 185 |
|
|
2018
Q3 | $416K | Hold |
8,271
| – | – | 0.05% | 137 |
|
|
2018
Q2 | $495K | Hold |
8,271
| – | – | 0.06% | 122 |
|
|
2018
Q1 | $379K | Buy |
+8,271
| New | +$379K | 0.05% | 140 |
|